mAbs and antibody variants

mAbs and antibody variants

Monoclonal antibodies (mAbs) treat many diseases and disorders. Antibody-based therapies have evolved over time to include other types – such as bispecifics, fragments, and conjugates.

mRNA

mRNA

mRNA technology has proven itself a flexible and versatile route for prophylactic vaccines. It also holds great promise for therapies and personalized cancer vaccines.
Oligonucleotides

Oligonucleotides

Oligonucleotide therapeutics are based on short, synthetic strands of DNA or RNA that prevent gene expression or hinder protein function by binding to a target gene or protein sequence.
Gene therapy

Gene therapy

Many gene therapy applications use plasmids and viral vectors to introduce and deliver genetic changes. Develop and manufacture both with proven equipment and support – from start to finish.
Vaccines

Vaccines

Vaccines based on novel molecules like mRNA and viral vectors are on the rise. Increase the opportunity to meet tomorrow’s vaccine manufacturing needs with innovative technologies and process strategies.
Cell therapies

Cell therapies

Cell therapies use live cells made by processes prone to errors, contamination, and inconsistency. Explore automated systems, reagents, and process development support for scalable manufacturing.